What is LOPJLB’s current signal on TPST?

LOPJLB’s latest quantitative signal on Tempest Therapeutics, Inc. (TPST) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is TPST in?

Tempest Therapeutics, Inc. (TPST) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Tempest Therapeutics, Inc. (TPST) do?

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial …

Where is Tempest Therapeutics, Inc. based / listed?

Tempest Therapeutics, Inc. is based in US, listed on NASDAQ.

Tempest Therapeutics, Inc. (TPST)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.76-1.30%Close

SELLCRISIS · day 17

[SCORES & PROFILE]

FUND: 4
VALUE: 7
GROWTH: 35
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-420.1%

GROSS

NET

[VALUATION]

P/E TTM-0.18

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B-11.00

P/FCF-

EV/EBITDA-0.48

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.38

ND/EBITDA-

BETA-1.71

Tempest Therapeutics, Inc. (TPST)

Key stats

Prediction markets

FUNDAMENTALS

Company news